Ketamine and Other Medications

At Ember Health, we defer to the expertise of each patient’s prescribing practitioners for all medication decision-making outside of our ketamine administration. Our goal is to ensure that our partners are fully informed about how their decision can impact our treatments, so that they can knowledgeably help our shared patients navigate their goals of care.
long term care nearby
Photo by Elena Mozhvilo on Unsplash

Medication Interactions

There are no routinely prescribed medications that are harmful when combined with ketamine. Ketamine has an excellent safety profile and few side effects. Patients are able to remain on their current oral antidepressant regimen when starting ketamine treatment.

Safety aside, there are a few medications that can affect ketamine’s antidepressant response: benzodiazepines, GABA-like substances, lamotrigine, and naltrexone are the most studied substances with these effects. Each is covered in further detail below, in order of the quality of the published evidence for their interaction with ketamine.

Prescribers should always discuss with their patient whether it is advisable to keep taking an existing medication as prescribed, and the risks and benefits of any changes.

 
a molecule structure with letters and numbers
a black line with a white background

Benzodiazepines & GABA-like substances

Benzodiazepines reduce the likelihood a patient experiences ketamine’s antidepressant effect (source). This interaction is dose dependent, with greater daily benzodiazepine loads, correlating with lower ketamine antidepressant effect. 

Our recommendation to our prescribing partners is to aim for the lowest tolerable dose of benzodiazepines, understanding that patients might not be able to tolerate weaning their existing medications. We will often frame this in the language of “lowest tolerable dose”.

If a patient takes a benzodiazepine on an “as needed” basis (PRN), we would suggest that the patient avoid taking them 24 hours before and after each infusion. If the medication is taken on a standing daily basis, we encourage the patient to have a detailed conversation with their prescribing practitioner to discuss whether or not tapering is advisable, the risks and benefits of doing so, and how it can be done safely.

Note that some long acting benzodiazepines (eg: Clonazepam) might warrant 36 hours before and after each infusion, given their longer half lives. The particular timing differences between different benzodiazepine agents has not yet been studied, and current recommendations are therefore made from expert consensus only.

While the interaction between other GABA-like substances and ketamine have not been explicitly studied, they have a similar mechanism to benzodiazepines. Hence we have the same recommendation for GABA-like substances as we do for benzodiazepines.

camicle

Lamotrigine

The published evidence is conflicting as to whether or not lamotrigine interacts with the antidepressant effect of ketamine. Both affect the NMDA receptor and have theory on why they could either augment, or negatively interact with each other.

Anecdotally, patients will comment about lamotrigine affecting the altered state of consciousness during a ketamine session. Generally speaking, patients will report less immersive experiences if they have recently taken their Lamotrigine prior to their infusion.

Given the current evidence, our guidelines are conservative, and we suggest skipping a dose of lamictal if it is scheduled within six hours prior to an infusion. Otherwise, Lamotrigine can be taken as prescribed.

a black and white diagram of a molecule

Naltrexone

The published evidence is conflicting as to whether or not naltrexone interacts with the antidepressant effect of ketamine.  Given the current mixed evidence, our guidelines are conservative, and we suggest skipping any doses of naltrexone that would be taken on the same calendar day of an infusion. Otherwise, naltrexone can be taken as prescribed.

Non-prescribed, regulated substances (alcohol, cannabis, etc.)

Research has yet to explore whether or not ketamine interacts with non-prescribed substances. Irrespective of ketamine, alcohol and cannabis are both known mood depressants and regular use has been linked to more frequent depressive states. 

While not yet studied, both alcohol in its GABA like effect, and cannabis with its role in altering memory formation have biological mechanisms of action that could reduce the benefit of ketamine for depression. Hence, we recommend that patients avoid alcohol and cannabis for 24 hours before and after each treatment.

Generally speaking, we encourage patients to reduce the use of these substances and avoid any other non-prescribed substance that could affect their mood or state of consciousness around our treatments. This is particularly important with our initial visits, when we need to avoid confounding variables that could affect treatment outcomes.

 

Weaning off of antidepressants

Many of our patients share a goal of weaning off of their oral antidepressant medications. If you believe this is an appropriate goal for your patient, know that ketamine treatments can play a supportive role in maintaining mood stability throughout a weaning process.

This topic is nuanced. Please be in touch directly with the Ember Clinical Director with whom you share your patient to discuss an individualized, structured maintenance treatment to support your shared patient’s goals.

In summary:

  • Our role is supportive to the patient’s prescribing providers.

  • Ketamine is safe in combination with other prescribed medications.

  • Certain prescriptions may mitigate ketamine’s antidepressant effect: benzodiazepines, GABA-like substances, lamotrigine, and naltrexone.

  • Certain non-prescribed substances may dampen ketamine’s antidepressant effect.

  • Ketamine treatment can provide a layer of support during a medication wean.